Form 4: Exelon Director Boosts Stake with Deferred Stock Units
Insider Transaction Disclosure
Exelon Corp. Director Marjorie Rodgers Cheshire acquired additional deferred stock units and phantom share equivalents, increasing her beneficial ownership.
Summary
- Marjorie Rodgers Cheshire, a Director at Exelon Corp. (EXC), acquired additional securities on December 31, 2025.
- She acquired 940 common stock-deferred stock units at a price of $43.87 per unit, bringing her indirect beneficial ownership to 24,638 units.
- The balance of deferred stock units includes 214 additional shares acquired through automatic dividend reinvestment.
- She also acquired 473 deferred phantom share equivalents at a price of $43.59 per equivalent, increasing her direct beneficial ownership to 9,512 equivalents.
- The balance of phantom share equivalents includes 82 additional equivalents accrued through automatic dividend reinvestment.
- Phantom share equivalents are held in a multi-fund, non-qualified deferred compensation plan and will be settled for cash on a 1-for-1 basis upon the termination of her service to the board of directors.
Sentiment
Score: 7
Explanation: The acquisition of additional shares and phantom equivalents by a director, including through dividend reinvestment, generally indicates confidence in the company's future prospects and aligns the director's interests with shareholders. This is a positive signal, though it's a routine disclosure for compensation.
Positives
- A director increasing their stake in the company, even through deferred compensation and dividend reinvestment, can signal confidence in future performance.
- The acquisition of deferred stock units and phantom share equivalents indicates continued alignment of the director's interests with shareholders.
Future Outlook
The filing indicates that deferred phantom share equivalents will be settled for cash on a 1-for-1 basis upon the termination of the reporting person's service to the board of directors, which is a future event related to the compensation plan.
Industry Context
This Form 4 filing is a routine disclosure of insider trading, common across all publicly traded companies. It reflects a director's personal investment decisions within the company's compensation framework, rather than broader industry trends.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive signal of management confidence in the company's future performance.
Next Steps
- Phantom share equivalents will be settled for cash on a 1-for-1 basis upon the termination of the reporting person's service to the board of directors.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of transaction for acquisition of deferred stock units and phantom share equivalents. |
| 01/02/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdWhile the director's acquisition of additional shares and phantom equivalents is a positive signal of confidence, a Form 4 filing primarily discloses insider transactions and does not provide comprehensive financial or strategic updates to warrant a 'buy' or 'sell' recommendation on its own. It reinforces a 'hold' position for existing investors, suggesting continued alignment of interests.
Keywords
Exelon, EXC, Insider Trading, Form 4, Director Stock Acquisition, Deferred Stock Units, Phantom Shares, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.